O-88 Gemcitabine and cisplatin (GC) +/-subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)

Publication | Closed Access

DOI

Citations

References

2003

Year

Maciel Krzakowski, M. Wenczl, Thomas Brodowicz, Valentina Tzekova, Rodryg Ramlau, N. Ghilezan, Branka Čučević, K. Gyurkovits, Ernst Ulsperger, Christoph Zielinski,

Lung Cancer

OncologySingle-agent GemcitabineMetronomic TherapyRandomized TrialCancer TreatmentMedicineRadiation OncologyLung CancerO-88 Gemcitabine